3 Stocks Improving Performance Of The Drugs Industry

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 42.44 points (-0.2%) at 17,080 as of Thursday, Aug. 28, 2014, 4:20 PM ET. The NYSE advances/declines ratio sits at 1,267 issues advancing vs. 1,750 declining with 176 unchanged.

The Drugs industry as a whole closed the day down 0.3% versus the S&P 500, which was down 0.2%. Top gainers within the Drugs industry included Aoxing Pharmaceutical ( AXN), up 2.7%, XTL Biopharmaceuticals ( XTLB), up 5.1%, Prima Biomed ( PBMD), up 1.9%, Cellectar Biosciences ( CLRB), up 1.6% and Evoke Pharma ( EVOK), up 2.7%.

TheStreet Ratings Group would like to highlight 3 stocks pushing the industry higher today:

Cellectar Biosciences ( CLRB) is one of the companies that pushed the Drugs industry higher today. Cellectar Biosciences was up $0.05 (1.6%) to $3.25 on heavy volume. Throughout the day, 49,994 shares of Cellectar Biosciences exchanged hands as compared to its average daily volume of 13,300 shares. The stock ranged in a price between $3.17-$3.35 after having opened the day at $3.29 as compared to the previous trading day's close of $3.20.

Cellectar Biosciences has a market cap of $9.3 million and is part of the health care sector. Shares are unchanged year-to-date as of the close of trading on Wednesday.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

Buy These 5 Stocks Now for Big Breakout Gains

3 Stocks Boosting The Health Care Sector Higher

3 Stocks Driving The Drugs Industry Higher

3 Stocks Pushing The Drugs Industry Lower

3 Stocks Driving The Drugs Industry Higher